APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

Clinical trial NCT03053466 · COMPLETED

Trial details

NCT number: NCT03053466
Sponsor: Apollomics (Australia) Pty. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Microsatellite Instability Mismatch Repair Deficiency Cancer of Unknown Primary Site

Start date: 2017-03-27
Primary completion: 2022-02-25
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.